November 14, 2025, 9:00 a.m. Research in the Parker Lab harnesses the power of proteomic technologies to elucidate mechanisms of vascular pathology and identify putative molecular biomarkers of aneurysm and atherosclerosis. HKRB 150
HKRB 150
Abby Burrows Franco, PhD
Sarah Parker, PhD
Cedars-Sinai Medical Center